Clinical Trial Services

Feb 01, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The author analyzes the results of a survey that polled pharmaceutical executives and managers about both sides of the outsourcing relationship. Read this and other preferred organization articles in this special issue.
Oct 01, 2010
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
The FDA has issued a final rule that clarifies what safety information must be reported during clinical trials of investigational drugs and biologics.
Aug 01, 2010
Pharmaceutical Technology
By Pharmaceutical Technology Editors
As emerging markets become increasingly important for the pharmaceutical majors, companies are re-evaluating their outsourcing strategies. This article is part of the 2010 Outsourcing Resources special issue.
Jul 22, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.
Jun 02, 2010
Pharmaceutical Technology
By Pharmaceutical Technology Editors
CROs and CMOs adapt their business models and capabilities to meet sponsor companies' need to reduce costs and accelerate development time.
Jun 01, 2010
Sponsored Content
By Pharmaceutical Technology Editors
From product development to finished patient kits, Rockwell Automation equipment is used throughout the entire process.
Mar 01, 2010
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The author examines the use and advantages of disposable technologies in the fill–finish of sterile pharmaceutical products and how these technologies can reduce costs and time in producing clinical-trial materials.
Jun 02, 2009
Pharmaceutical Technology
By Pharmaceutical Technology Editors
CROs and CMOs expand to gain a piece of the market for clinical trial materials.
May 01, 2009
Pharmaceutical Technology Europe
The CRO market is experiencing two-tiered growth: firstly from pharmaceutical companies seeking to lower fixed costs by outsourcing clinical research to CROs; and secondly, from biotechnology and specialty pharmaceutical companies that lack the infrastructure to conduct trials.
Sep 03, 2008
PTSM: Pharmaceutical Technology Sourcing and Management
CMC service providers are doing well, but clinical and preclinical CROs are doing even better.
native1_300x100
lorem ipsum